Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byBioMarin Pharmaceutical
Date1/2013

General Information

Offices

San Diego, USA
5626 Oberlin Drive
Suite 100
San Diego, CA, 92121
USA

People

Chief Financial Officer
President and Chief Executive Officer
Director
Chief Scientific Officer

Funding

TOTAL $533k
FUNDING TOTAL $533k
Venture Round, 6/2010
$500k
Convertible Note, 4/2012
$33k

Tags

Zacharon Pharmaceuticals

Zacharon Pharmaceuticals is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans. Zacharon was incorporated in 2004 and has received initial funding through NIH grants and individual investors. Series A financing was more recently provided by Avalon Ventures, a long-standing San Diego-based venture capital firm with a focus on early stage life science companies. With this strong financial backing and innovative drug development platform in place, Zacharon is developing an entirely new class of human therapeutics addressing substantial unmet needs.

Recent Milestones

Videos

Screenshots

Zacharon Pharmaceuticals screenshot
Above: Zacharon Pharmaceuticals
Uploaded: 1/9/13

Sources

  1. BioMarin Acquires Zacharon Pharmaceuticals (finance.yahoo.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/31/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy